CBWTF
Price
$0.11
Change
-$0.00 (-0.00%)
Updated
Aug 12 closing price
Capitalization
145.66M
CRLBF
Price
$1.04
Change
+$0.05 (+5.05%)
Updated
Aug 12 closing price
Capitalization
364.37M
86 days until earnings call
Interact to see
Advertisement

CBWTF vs CRLBF

Header iconCBWTF vs CRLBF Comparison
Open Charts CBWTF vs CRLBFBanner chart's image
Auxly Cannabis Group
Price$0.11
Change-$0.00 (-0.00%)
Volume$1.8M
Capitalization145.66M
Cresco Labs
Price$1.04
Change+$0.05 (+5.05%)
Volume$3.45M
Capitalization364.37M
CBWTF vs CRLBF Comparison Chart in %
Loading...
CBWTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CBWTF vs. CRLBF commentary
Aug 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBWTF is a Hold and CRLBF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 14, 2025
Stock price -- (CBWTF: $0.11 vs. CRLBF: $1.04)
Brand notoriety: CBWTF and CRLBF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CBWTF: 146% vs. CRLBF: 341%
Market capitalization -- CBWTF: $145.66M vs. CRLBF: $364.37M
CBWTF [@Pharmaceuticals: Generic] is valued at $145.66M. CRLBF’s [@Pharmaceuticals: Generic] market capitalization is $364.37M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $66.38B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBWTF’s FA Score shows that 1 FA rating(s) are green whileCRLBF’s FA Score has 0 green FA rating(s).

  • CBWTF’s FA Score: 1 green, 4 red.
  • CRLBF’s FA Score: 0 green, 5 red.
According to our system of comparison, CBWTF is a better buy in the long-term than CRLBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBWTF’s TA Score shows that 3 TA indicator(s) are bullish while CRLBF’s TA Score has 5 bullish TA indicator(s).

  • CBWTF’s TA Score: 3 bullish, 4 bearish.
  • CRLBF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CRLBF is a better buy in the short-term than CBWTF.

Price Growth

CBWTF (@Pharmaceuticals: Generic) experienced а -0.73% price change this week, while CRLBF (@Pharmaceuticals: Generic) price change was +47.52% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +61.79%. For the same industry, the average monthly price growth was +12.64%, and the average quarterly price growth was +81.83%.

Reported Earning Dates

CRLBF is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+61.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRLBF($364M) has a higher market cap than CBWTF($146M). CBWTF YTD gains are higher at: 305.576 vs. CRLBF (13.819). CRLBF has higher annual earnings (EBITDA): 95.7M vs. CBWTF (33.7M). CRLBF has more cash in the bank: 155M vs. CBWTF (17.3M). CBWTF has less debt than CRLBF: CBWTF (65.3M) vs CRLBF (646M). CRLBF has higher revenues than CBWTF: CRLBF (706M) vs CBWTF (130M).
CBWTFCRLBFCBWTF / CRLBF
Capitalization146M364M40%
EBITDA33.7M95.7M35%
Gain YTD305.57613.8192,211%
P/E Ratio5.00N/A-
Revenue130M706M18%
Total Cash17.3M155M11%
Total Debt65.3M646M10%
FUNDAMENTALS RATINGS
CBWTF vs CRLBF: Fundamental Ratings
CBWTF
CRLBF
OUTLOOK RATING
1..100
5723
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4795
PRICE GROWTH RATING
1..100
3539
P/E GROWTH RATING
1..100
12100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CBWTF's Valuation (54) in the null industry is in the same range as CRLBF (77). This means that CBWTF’s stock grew similarly to CRLBF’s over the last 12 months.

CBWTF's Profit vs Risk Rating (100) in the null industry is in the same range as CRLBF (100). This means that CBWTF’s stock grew similarly to CRLBF’s over the last 12 months.

CBWTF's SMR Rating (47) in the null industry is somewhat better than the same rating for CRLBF (95). This means that CBWTF’s stock grew somewhat faster than CRLBF’s over the last 12 months.

CBWTF's Price Growth Rating (35) in the null industry is in the same range as CRLBF (39). This means that CBWTF’s stock grew similarly to CRLBF’s over the last 12 months.

CBWTF's P/E Growth Rating (12) in the null industry is significantly better than the same rating for CRLBF (100). This means that CBWTF’s stock grew significantly faster than CRLBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBWTFCRLBF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
89%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CBWTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCUPX20.310.17
+0.84%
NYLI PineStone U.S. Equity Class P
RCGTX15.66N/A
N/A
Virtus Zevenbergen Technology C
TLGYX66.16N/A
N/A
Touchstone Large Company Growth Y
EMQCX8.79N/A
N/A
Ashmore Emerging Markets Active Eq C
VGRIX80.73N/A
N/A
JPMorgan US Value A

CBWTF and

Correlation & Price change

A.I.dvisor tells us that CBWTF and CRLBF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CBWTF and CRLBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBWTF
1D Price
Change %
CBWTF100%
-0.82%
CRLBF - CBWTF
21%
Poorly correlated
+5.05%
BUDZ - CBWTF
14%
Poorly correlated
-1.90%
CNTMF - CBWTF
13%
Poorly correlated
-3.95%
CPHRF - CBWTF
8%
Poorly correlated
+0.18%
CANQF - CBWTF
6%
Poorly correlated
+39.60%
More

CRLBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TSNDF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
+5.05%
TSNDF - CRLBF
76%
Closely correlated
+1.33%
CURLF - CRLBF
76%
Closely correlated
-1.45%
TCNNF - CRLBF
75%
Closely correlated
-4.70%
JUSHF - CRLBF
74%
Closely correlated
-13.37%
VRNOF - CRLBF
73%
Closely correlated
+7.13%
More